Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.
about
Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related AnalogsAnnual banned-substance review: analytical approaches in human sports drug testing.Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry.Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.Colorado Cannabis Legalization and Its Effect on Emergency CareAcute Poisonings from Synthetic Cannabinoids - 50 U.S. Toxicology Investigators Consortium Registry Sites, 2010-2015.The potential role of cannabinoids in epilepsy treatment.High-resolution mass spectrometry in toxicology: current status and future perspectives.New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics.25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans?Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study.Screening for illicit drugs in pooled human urine and urinated soil samples and studies on the stability of urinary excretion products of cocaine, MDMA, and MDEA in wastewater by hyphenated mass spectrometry techniques.Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.Simple screening procedure for 72 synthetic cannabinoids in whole blood by liquid chromatography-tandem mass spectrometry.Behavioral and Pharmacokinetic Profile of Indole-Derived Synthetic Cannabinoids JWH-073 and JWH-210 as Compared to the Phytocannabinoid Δ-THC in Rats
P2860
Q30244676-2DDF3E83-F193-4D5E-A622-B91B19A11F7BQ33566201-9397F43E-9ADE-46EE-965F-B486BDC7E6C8Q34509038-809B4B5E-B978-4858-A0A1-A4AAF712CA0FQ34519359-4ACC3560-3C38-4C89-BF76-EF0B3569B70EQ36950560-6BFA9BD7-32B3-4635-8A97-673A3FAE0BFCQ37082254-80000397-9F7B-440D-9E88-F70C7E13333DQ37149595-EA9D2B1B-8049-4070-B3C9-AC3CD4AEF1EEQ38606080-6FF69E94-38EE-4727-AEF9-12A72F816785Q38846184-D57CD613-C8D3-4F63-AF5E-E33514BD1292Q38963846-1D0079C0-2933-456B-855B-678BB8EF7A9DQ39569585-30BA17B9-B1E8-4A92-A0C7-357808EB75D7Q39666362-D18BF1C5-DA10-425A-929D-4879AFEC258FQ40225910-3D13E8EE-6F99-4990-8FFA-3A4ED62521BAQ40248909-1E3E41F4-FED1-44E6-A6C1-92F61B625FDEQ40903642-ABC8EBFD-2C4B-44F2-B010-C4A929418AC9Q48301733-9F026601-45C4-48DE-BB02-B6EFDAD043FBQ55425177-6F96492D-84E1-4AC0-87D4-A546F13113ECQ58573307-C15E97E8-D3CC-44DD-8A59-553B11BDCE8A
P2860
Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.
@en
type
label
Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.
@en
prefLabel
Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.
@en
P2093
P2860
P1476
Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.
@en
P2093
Ariane Wohlfarth
David A Gorelick
Marisol S Castaneto
Nathalie A Desrosiers
Rebecca L Hartman
P2860
P304
P356
10.3109/03602532.2015.1029635
P407
P577
2015-04-08T00:00:00Z